导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.94% | 1981/4773 |
| 近一周 | -2.87% | 3300/5462 |
| 近一月 | -4.82% | 2789/5421 |
| 近一季 | -7.68% | 2492/5209 |
| 近半年 | -8.12% | 3309/4920 |
| 近一年 | 5.61% | 1573/4366 |
| 近两年 | 68.98% | 992/2954 |
| 近三年 | 31.62% | 985/2253 |
| 成立以来 | 102.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.02% 1094/4961 |
10.97% 2381/5312 |
- - |
- - |
| 2025 | 29.47% 1396/4813 |
2.65% 1300/3635 |
1.72% 2203/4076 |
22.59% 1635/4524 |
1.15% 1502/4813 |
| 2024 | 5.95% 1799/3463 |
-3.47% 1505/2808 |
-6.14% 1865/3014 |
17.05% 1281/3129 |
-0.09% 1315/3463 |
| 2023 | -3.73% 648/2656 |
9.06% 428/2280 |
-3.68% 861/2385 |
-4.05% 1046/2515 |
-4.49% 1060/2655 |
| 2022 | -15.53% 421/2207 |
-11.59% 532/1919 |
2.11% 1351/2016 |
-10.28% 376/2113 |
4.29% 564/2208 |
| 2021 | 21.10% 168/1822 |
0.29% 305/1255 |
9.25% 573/1330 |
6.46% 224/1466 |
3.82% 386/1822 |
| 2020 | 29.42% 539/1250 |
-5.55% 429/1028 |
17.00% 397/1067 |
13.21% 339/1164 |
3.45% 915/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 前海开源中证500等权ETF VS. 长安沪深300非周期A(740101) |